Prevalence of Helicobacter pylori seropositivity among patients undergoing bariatric surgery: A preliminary study

World Journal of Surgery

Volumn 32, Issue 9, 2008, Pages 2021-2025

  Erim, Tolga ^a   Cruz Correa, Marcia R ^b   Szomstein, Samuel ^c   Velis, Evelio ^d   Rosenthal, Raul ^c  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c Bariatric Institute   (United States)

^d BARRY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; BARIATRIC SURGERY; BODY MASS; CAUCASIAN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HELICOBACTER PYLORI SEROPOSITIVITY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PROBABILITY; RACE DIFFERENCE; RISK FACTOR; SERODIAGNOSIS; SEROLOGY; SEROPREVALENCE; SEX DIFFERENCE; UNITED STATES;

ADULT; AGED; BARIATRIC SURGERY; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLORIDA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; PREVALENCE; RISK FACTORS;

EID: 49749143348     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-008-9608-7     Document Type: Article

References (28)

1. National Center for Health Statistics NHANES IV Report. http://www.cdc.gov/nchs/nhanes.htm
2. KM Flegal MD Carroll CL Ogden 2002 Prevalence and trends in obesity among US adults, 1999-2000 JAMA 288 1723 1727
3. H Buchwald Y Avidor E Braunwald 2004 Bariatric surgery: A systematic review and meta-analysis JAMA 292 14 1724 1737
4. BJ Marshall HM Windsor 2005 The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention Med Clin North Am 89 313 344
5. International Agency for Research on Cancer 1994 Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994 IARC Monogr Eval Carcinog Risks Hum 61 177 241
6. A Ramaswamy E Lin BJ Ramshaw 2004 Early effects of Helicobacter pylori infection in patients undergoing bariatric surgery Arch Surg 139 1094 1096
7. B Schirmer C Erenoglu A Miller 2002 Flexible endoscopy in the management of patient undergoing Roux-en-Y gastric bypass Obes Surg 12 634 638
8. PK Papasavas DJ Gagné PE Donnelly 2008 Prevalence of Helicobacter pylori infection and value of preoperative testing and treatment in patients undergoing laparoscopic Roux-en-Y gastric bypass Surg Obes Relat Dis 4 3 383 388
9. AA Renshaw JR Rabaza AM Gonzalez 2001 Helicobacter pylori infection in patients undergoing gastric bypass surgery for morbid obesity Obes Surg 11 3 281 283
10. L Fontana JC Eagon M Colonna 2007 Impaired mononuclear cell immune function in extreme obesity is corrected by weight loss Rejuvenation Res 10 1 41 46
11. RW O'Rourke T Kay EA Lyle 2006 Alterations in peripheral blood lymphocyte cytokine expression in obesity Clin Exp Immunol 146 1 39 46
12. S Amar Q Zhou Y Shaik-Dasthagirisaheb 2007 Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge Proc Natl Acad Sci U S A 104 51 20466 20471
13. AG Smith PA Sheridan JB Harp 2007 Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus J Nutr 137 1236 1243
14. MS Wu WJ Lee HH Wang 2005 A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan Arch Intern Med 165 13 1552 1555
15. EJ Kuipers EC Klinkenberg-Knol CM Vandenbroucke-Grauls 1997 Role of Helicobacter pylori in the pathogenesis of atrophic gastritis Scand J Gastroenterol 223 28 34
16. K Ohkuma M Okada H Murayama 2000 Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia J Gastroenterol Hepatol 15 1105 1112
17. M Asaka T Sugiyama A Nobuta 2001 Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study Helicobacter 6 294 299
18. P Malfertheiner F Megraud C O'Morain 2007 Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report Gut 56 6 772 781
19. AV Safatle-Ribeiro R Kuga K Iriya Ribeiro 2007 What to expect in the excluded stomach mucosa after vertical banded Roux-en-Y gastric bypass for morbid obesity J Gastrointest Surg 11 2 133 137
20. K Kihira K Satoh K Saifuku 1996 Endoscopic topical therapy for the treatment of Helicobacter pylori infection J Gastroenterol 31 Suppl 9 66 68
21. K Satoh 1996 Treatment of Helicobacter pylori infection by topical administration of antimicrobial agents. Scand J Gastroenterol Suppl 214 56 discussion 57-60
22. CU Nwokolo P Mistry RE Pounder 1990 The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate) Aliment Pharmacol Ther 4 163 169
23. MW Whitehead RH Phillips CE Sieniawska 2000 Double-blind comparison of absorbable colloidal bismuth subcitrate and nonabsorbable bismuth subnitrate in the eradication of Helicobacter pylori and the relief of nonulcer dyspepsia Helicobacter 5 169 175
24. M Moshkowitz FM Konikoff Y Peled 1995 High Helicobacter pylori numbers are associated with low eradication rate after triple therapy Gut 36 845 847
25. BS Sheu HB Yang IJ Su 1996 Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer Gastrointest Endosc 44 683 688
26. F Megraud MP Brassens Rabbe F Denis 1989 Seroepidemiology of Campylobacter pylori infection in various populations J Clin Microbiol 27 1870 1873
27. M Woodward C Morrison K McColl 2000 An investigation into factors associated with Helicobacter pylori infection J Clin Epidemiol 53 175 181
28. MF Go 2002 Review article: natural history and epidemiology of Helicobacter pylori infection Aliment Pharmacol Ther 16 Suppl 1 3 15